GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Total Assets

Actelion (Actelion) Total Assets : $2,332 Mil (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Actelion Total Assets?

Actelion's Total Assets for the quarter that ended in Mar. 2017 was $2,332 Mil.

Total Assets is connected with ROA %. Actelion's annualized ROA % for the quarter that ended in Mar. 2017 was 35.77%. Total Assets is also linked to Revenue through Asset Turnover. Actelion's Asset Turnover for the quarter that ended in Mar. 2017 was 0.29.


Actelion Total Assets Historical Data

The historical data trend for Actelion's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Total Assets Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,924.44 3,391.70 2,817.41 1,924.37 2,066.39

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,059.89 2,047.42 2,054.81 2,066.39 2,332.19

Actelion Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Actelion's Total Assets for the fiscal year that ended in Dec. 2016 is calculated as

Total Assets=Total Equity (A: Dec. 2016 )+Total Liabilities (A: Dec. 2016 )
=1296.015+770.374
=2,066

Actelion's Total Assets for the quarter that ended in Mar. 2017 is calculated as

Total Assets=Total Equity (Q: Mar. 2017 )+Total Liabilities (Q: Mar. 2017 )
=1605.81+726.38
=2,332

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actelion  (OTCPK:ALIOF) Total Assets Explanation

Total Assets is connected with ROA %.

Actelion's annualized ROA % for the quarter that ended in Mar. 2017 is

ROA %=Net Income (Q: Mar. 2017 )/( (Total Assets (Q: Dec. 2016 )+Total Assets (Q: Mar. 2017 ))/ count )
=786.648/( (2066.389+2332.191)/ 2 )
=786.648/2199.29
=35.77 %

Note: The Net Income data used here is four times the quarterly (Mar. 2017) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Actelion's Asset Turnover for the quarter that ended in Mar. 2017 is

Asset Turnover
=Revenue (Q: Mar. 2017 )/( (Total Assets (Q: Dec. 2016 )+Total Assets (Q: Mar. 2017 ))/ count )
=645.285/( (2066.389+2332.191)/ 2 )
=645.285/2199.29
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Actelion Total Assets Related Terms

Thank you for viewing the detailed overview of Actelion's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Actelion (Actelion) Business Description

Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 01-24-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson 08-03-2016

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 02-14-2017

Actelion Still On Growth Track

By reports.droy reports.droy 02-18-2015